News | ACC | July 15, 2022

ACC Names Dr. Melvin Echols as Chief Diversity, Equity and Inclusion Officer

The ACC has named Melvin R. Echols, MD, FACC, as its new Chief Diversity, Equity and Inclusion Officer

Melvin R. Echols, MD, FACC 


July 15, 2022 — The ACC has named Melvin R. Echols, MD, FACC, as its new Chief Diversity, Equity and Inclusion Officer, effective July 18. Echols will lead the College’s diversity, equity and inclusion strategy and programs, while also maintaining a portion of his current clinical and research responsibilities at Morehouse School of Medicine in Atlanta. 

"Fostering a diverse and inclusive cardiovascular workforce, while also advancing solutions to improve health equity among individual patients and populations, is fundamental to achieving ACC’s Mission of transforming cardiovascular care and improving heart health for all,” said ACC CEO Cathleen C. Gates. “As both a cardiologist and a cardiovascular disparities researcher, Dr. Echols brings a deep understanding of the profession, as well as demonstrated success in effectively advancing diversity, equity and inclusion initiatives and driving cultural change – competencies that will undoubtedly ensure we are able to deliver on our strategic diversity, equity and inclusion goals now and into the future.” 

Echols is currently an associate professor of cardiovascular disease at Morehouse School of Medicine and serves as program director for the Cardiovascular Disease Fellowship. He is also a practicing cardiologist specializing in heart failure and brings more than a decade of experience as a clinical trial investigator focusing on heart failure, quality improvement, social determinants of health, and health care disparities. In his role as Chief Diversity, Equity and Inclusion Officer, Echols will use his expertise and experiences to work with ACC members, staff, external partners and other stakeholders to identify and implement programmatic goals and develop actionable and sustainable solutions to achieving a more diverse, equitable and inclusive College and cardiovascular profession. Specifically, he will lead and facilitate ACC efforts to mitigate barriers to entry into the field of cardiology; build and expand educational initiatives like the new Internal Medicine Program; and lead and coordinate the diversity and inclusion efforts and training of both staff and members across the College. 

“In a time where polarization continues to permeate our society, we need the implicit core values of diversity, equity, and inclusion now more than ever,” Echols said. “I expect this role will permit me to listen actively, learn vigorously, and allow the needs of our society to lead the ACC towards impactful change.” 

Echols graduated from Morehouse School of Medicine in 2002 and completed Internal Medicine at Duke University in 2005. He completed his cardiovascular fellowship training at Duke University Medical Center. He is a member of the ACC, Association of Black Cardiologists, the Heart Failure Society of America, the American Society of Preventive Cardiology, and the American Heart Association

“The discovery of commonalities between people and culture while providing quality cardiovascular care to all is strengthened by diversity, and will ultimately improve health equity in our society,” Echols said. “Everyone has a part to play in this mission and should feel included in helping to make our society and the world better than yesterday.” 

For more information: www.acc.org 

Find more ACC22 conference coverage 

Related Content

News | Heart Failure

August 8, 2022 — A major risk factor for diabetes, insulin resistance occurs when the cells of the body do not respond ...

Home August 08, 2022
Home
News | Heart Failure

August 5, 2022 — For people with coronary heart disease, beta-blockers can improve survival and quality of life, while ...

Home August 05, 2022
Home
News | Heart Failure

July 27, 2022 — The world’s first HIV-positive to HIV-positive heart transplant has been successfully performed at ...

Home July 27, 2022
Home
News | Heart Failure

July 27, 2022 — Researchers from RCSI University of Medicine and Health Sciences have developed a new lab-based model of ...

Home July 27, 2022
Home
News | Heart Failure

July 20, 2022 — Sequana Medical NV, a pioneer in the treatment of drug-resistant fluid overload in liver disease and ...

Home July 20, 2022
Home
News | Heart Failure

July 15, 2022 — The American Heart Association, the leading voluntary organization devoted to longer, healthier lives ...

Home July 15, 2022
Home
News | Heart Failure

July 13, 2022 — Ancora Heart, Inc., a company developing a novel device-based therapy to address heart failure, today ...

Home July 13, 2022
Home
News | Heart Failure

July 12, 2022 — Pesticides and heavy metals in soil may have detrimental effects on the cardiovascular system, according ...

Home July 12, 2022
Home
News | Heart Failure

July 7, 2022 — Tenaya Therapeutics, Inc., a biotechnology company with a mission to discover, develop and deliver ...

Home July 07, 2022
Home
News | Heart Failure

June 29, 2022 — A spiral wave of electrical activity in the heart can cause catastrophic consequences. One spiral wave ...

Home June 29, 2022
Home
Subscribe Now